NEOGENOMICS INC — Director's Dealing 2023

Aug 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2023-08-10

Reporting Person: Kelly Michael Aaron (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-10	Stock Option (Right to Buy)	$14.82	A	8353	Acquired	2033-08-10	Common Stock (8353)	Direct
2023-08-10	Restricted Stock Unit	$0	A	11336	Acquired		Common Stock (11336)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20419	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$37.53	2027-05-28	Common Stock (2223)	2223	Direct
Stock Option (Right to Buy)	$40.90	2028-06-02	Common Stock (3714)	3714	Direct
Stock Option (Right to Buy)	$8.10	2029-06-10	Common Stock (13882)	13882	Direct

Footnotes

F1: Once vested, the shares of common stock are not subject to expiration.